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Abstract
The primary aim of in vitro testing of chemicals delivered via the percutaneous route is to
predict the absorption that would ensue if exposure occurred in live animals. While there
is mounting evidence that in vitro diffusion studies in mammalian skin can provide valid
information regarding likely in vivo absorption, little is known whether such a correlation
exists between in vitro diffusion testing and in vivo blood levels in amphibians. The current
study used previously-reported in vitro absorption data for caffeine, benzoic acid, and ibu-
profen across isolated skin from the cane toad (Rhinella marina) to produce a series of lin-
ear mixed-effect models of the absorption parameters flux and permeability coefficient
(Kp). Models investigated the relative impacts of animal weight, physicochemical charac-
teristics of the applied chemical (logP or molecular weight), and site of application. The
top models were then used to predict the flux, Kp and serum concentrations of the same
three model chemicals. Finally, the absorption of these chemicals was determined in live
cane toads, and results compared to the model predictions. LogP and site of application
were included in all top models. In vivo absorption rates were lower than predicted for all
chemicals, however, the models provided reasonable predictions of serum concentration,
with factors of difference (FOD) ranging from 2.5–10.5. Ibuprofen, the chemical with the
highest relative lipophilicity, had the poorest predictive performance, consistently having
the highest FOD for all predictions. This report presents the first models of percutaneous
absorption in an amphibian. These models provide a basic method to establish the
approximate in vivo absorption of hydrophilic and moderately-lipophilic chemicals through
frog skin, and could therefore be used to predict absorption when formulating such chemi-
cals for treatment of disease in frogs, or for risk-assessments regarding chemical pollut-
ants in frog habitats.
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In vitro methods are commonly used in place of in vivo experimentation to predict the percu-
taneous absorption of chemicals for both drug development and risk assessment. The diffusion
cell, an apparatus that holds either excised skin or a synthetic membrane between two glass
chambers, is the most commonly-used and recommended in vitro technique to measure drug
penetration for both development and equivalence testing of therapeutic formulations, and
dermal exposure risk assessments [1, 2]. However, in vitro methods need to be validated by
comparison to the in vivo situation, to assess their relevance and application to practice.
Percutaneous absorption studies in human and other mammalian species have found mod-
erate correlation between in vitro methods and results in vivo, provided that study methods
are sufficiently harmonized with regard to donor composition (vehicle and dose), skin source,
occlusion of the skin, exposure time, receptor fluid composition, and diffusion area [3–6].
However, until recently no established guidelines have specifically addressed in vitro-in vivo
correlation for transdermal drug products, and much discrepancy still remains with regards to
harmonisation between studies. The European Medicines Agency has attempted to rectify this,
recently releasing draft guidelines to advise in vitro-in vivo correlation for transdermal drug
products for consultation [7].
Amphibians have highly permeable skin, providing an ideal surface for absorption of chem-
icals. However, relatively few studies exist that investigate the absorption kinetics of chemicals
through frog skin (for review, see [8]). Recent risk assessment guidelines have highlighted the
detrimental impact of this heightened permeability coupled with lack of absorption kinetics
studies on frog health, and have recommended 100% absorption be assumed for all chemicals
through frog skin until further research has been conducted [9]. While there are several studies
that report on the absorption of chemicals in frog skin in vitro [10–17], only Riviere, Shapiro
[11] and Roberts, Berger [17] have also reported on in vivo absorption for their investigated
chemicals. Both studies reported lower in vivo drug levels than those found in the concurrent
in vitro studies, however the magnitude of difference varied, with Riviere, Shapiro [11] report-
ing serum concentrations of gentamycin 9–12-fold lower than those predicted based on the in
vitro studies, while Roberts, Berger [17] reported terbinafine concentrations of 0.22 μg/mm2
following 5 hours exposure in vitro, and 0.1 μg/mm2 following 4 hours exposure in vivo.
Owing to the conflicting results of these two studies, and the lack of other studies reporting
both in vitro and in vivo absorption in frog skin, it remains to be ascertained whether the
remaining reports of in vitro absorption through frog skin [10–17] can be reliably translated to
the in vivo situation.
The current study builds on previous work by the authors to determine how closely in vitro
absorption studies in frogs correlate with the in vivo situation. Firstly, previously-collected in
vitro percutaneous absorption data [13] were used to produce a model of percutaneous
absorption in the cane toad (Rhinella marina). The developed model was then used to predict
the in vivo absorption of a series of model chemicals, and finally the absorption of the same
chemicals was measured in healthy adult cane toads, and results compared.
Materials and methods
Chemicals and solutions
Model chemicals were reagent grade caffeine, ACS reagent grade benzoic acid (both Sigma-
Aldrich) and�98% ibuprofen (Sigma). Amphibian Ringer’s solution (ARS) was prepared
according to [18]: 113 mM sodium chloride, 2 mM potassium chloride, 1.35 mM calcium
chloride, 2.4 mM sodium bicarbonate. Model drug solutions were prepared as described
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previously by the authors for in vitro absorption studies in cane toads [13]: a saturated solution
for each of the model chemicals was prepared in ARS, with ibuprofen solutions also containing
2.75 mg/mL 2-hydroxypropyl-beta-cyclodextrin (HPβCD; Aldrich Chemistry) to ensure ade-
quate solubilization of ibuprofen. Ethyl 3-aminobenzoate methane sulfonate (MS-222; Aldrich
Chemistry) was prepared as a 0.2% w/v bathing solution in purified water, buffered to pH 7.3
with sodium bicarbonate, or as a 12.5% w/v injection in purified water, unbuffered [19].
Serum extractions used either hydrochloric acid (analytical grade; Ajax Finechem PTY
LTD) and dichloromethane (high-performance liquid chromatography (HPLC) grade; Bur-
dick & Jackson) or ethyl acetate (reagent grade; Ajax Finechem PTY LTD). HPLC mobile
phase was methanol (HPLC grade; Fisher Chemicals, Trinidad and Thermo Fisher Scientific,
Australia) and ultrapure water (Milli-Q Integral, Millipore Australia), acidified with 0.2% v/v
acetic acid (analytical grade; RCI LabScan, Thailand). Water used throughout was ultrapure
(Milli-Q Integral, Millipore Australia). All solutions were freshly prepared on the day of use.
Animal husbandry
Adult male cane toads (Rh. marina) were wild-caught in the Townsville region (Australia) and
transported to the laboratory, where they were housed in a dedicated room maintained at 21
±2˚C. Ninety-two animals were used for the study, weighing 71.61 g–138.16 g (mean 98.48 g).
Animals were housed in plastic tubs (60 x 36 x 40 cm); each tub had a lid with holes to permit
airflow, and had its interior base lined with absorbent paper. Three or four animals were
housed in each tub, which also provided two retreat sites and a water dish. Water was provided
ad libitum, and toads were fed crickets dusted with calcium and multivitamin powder (Veta-
farm Herpevet Multical Dust) every 2–3 days, with all toads fed for the last time two days
before the study commenced. Animals were housed for at least five days prior to testing, to
allow for acclimation to their surrounds. All animal handling, husbandry, and experimental
methodology was approved by the James Cook University Animal Ethics Committee (A2551).
In vivo study
Prior to the study commencing, each animal was rinsed with ARS to ensure the skin was clean,
and animal weight was recorded. Animals were then transferred to individual plastic contain-
ers for commencement of the trial.
For each individual chemical trial, 25 mL of saturated chemical solution was transferred to
a plastic zip-lock bag. Each animal was transferred to an individual bag and each bag placed in
an individual plastic container that restricted movement, ensuring relatively consistent expo-
sure of the ventral pelvic skin region to the chemical solution. In contrast to previous in vitro
studies by the authors [13] where chemical application was measured specifically in skin sam-
ples from dorsal, ventral thoracic and ventral pelvic, isolating aqueous drug solution applica-
tion to only the dorsal or ventral thoracic skin surfaces is impossible in live frogs. As frogs
naturally sit with their pelvic ventrum in small bodies of water (e.g., puddles), application to
this region is relatively easy, and mimics real-world conditions.
Animals were randomly allocated to a chemical treatment and sampling time using random
number generator software. Samples were obtained at t = 0, 30, 60, 90, 120, 150, 180, 240, 300,
360 minutes for benzoic acid, t = 0, 30, 60, 90, 120, 180, 240, 300, 360 minutes for ibuprofen,
and t = 5, 10, 15, 20, 25, 30 minutes for caffeine. Exposure and sampling times for benzoic acid
and ibuprofen were selected to match those used in previous in vitro studies. Sampling times
for caffeine were revised following a preliminary trial which suggested restlessness in animals
exposed to caffeine for more than 30 minutes. For each chemical trial, four animals were sacri-
ficed at each sampling time, in accordance with dermal absorption guidelines [20].
PLOS ONE Can models of percutaneous absorption based on in vitro data in frogs predict in vivo absorption?
PLOS ONE | https://doi.org/10.1371/journal.pone.0235737 July 29, 2020 3 / 14
At each sampling time, animals were removed from their bathing solution and rinsed in
fresh purified water. Each toad was then anaesthetised by intracoelomic injection of 400 mg/
kg MS-222 [19], and once a deep plane of anaesthesia was achieved, the thoracic cavity was
opened and 1 mL of cardiac blood was removed via a heparinised capillary tube into an Eppen-
dorf tube. A deep plane of anaesthesia was achieved within 2 minutes of administration of MS-
222 for all animals. Following sample collection, each animal was euthanized by placing in a
bath of 0.2% w/v MS-222, buffered with sodium bicarbonate. Blood samples were allowed to
clot, then centrifuged at 12,000 RCF for 10 minutes to separate serum. 0.5 mL aliquots of
serum were then transferred to Eppendorf tubes, and were stored at –80˚C until analysis.
Sample extraction
Extraction of ibuprofen and benzoic acid was based on the method described by Kearns and Wil-
son [21]. Briefly, 0.2 mL of 5M hydrochloric acid was added to 0.5 mL thawed serum, the mixture
was vortexed for 60 seconds, and 3 mL dichloromethane added. The resultant mixture was vor-
texed for a further 2 minutes, and then centrifuged at 3,200 RCF for 5 minutes at 4˚C. The organic
layer was then transferred to a clean glass tube and gently dried under nitrogen gas at 35˚C. Evap-
orated samples were reconstituted with 1 mL of mobile phase (60% methanol in water with 0.2%
acetic acid), vortexed and then centrifuged a final time for 5 minutes. The clear supernatant was
transferred to a sample vial and transported to the analytical laboratory for analysis.
For extraction of caffeine, 7 mL of ethyl acetate was added to each thawed 0.5 mL aliquot of
serum. The sample was then vortexed for 60 seconds and centrifuged at 3,200 RCF for 5 min-
utes at 22˚C. Supernatant was then transferred to a clean glass tube and dried overnight at
37˚C in a rotary dryer. Evaporated samples were reconstituted with 1 mL of mobile phase, vor-
texed and then centrifuged a final time at 3,200 RCF for 5 minutes. The clear supernatant was
transferred to a sample vial and samples transferred to the analytical laboratory for analysis.
Preliminary studies indicated that 98% of caffeine was present following a single extraction,
and so further extractions were not performed.
Ultra-high-performance liquid chromatography (UHPLC)
Analysis of serum samples was performed on a Shimadzu UHPLC Nexera X2, with an SPD-M30A
Diode Array Detector. Post-run analysis was performed using Labsolutions 5.89 (Shimadzu). Sepa-
ration was achieved on an Applied Biosystems SPHERI-5 5 Micron ODS column (250 x 4.6 mm)
at 38˚C. The mobile phase was a gradient with a total run time of 15 minutes, consisting of 0.2% v/
v acetic acid in water and 0.2% v/v acetic acid in methanol, as follows: 0–12 minutes increasing
from 50 to 85% methanol, remaining at 85% methanol for the final 3 minutes. Flow rate was 1 mL/
min. Injection volumes were 50 μL for ibuprofen and benzoic acid, and 10 μL for caffeine. Quanti-
fication was at 242 nm for all chemicals. All samples were analysed in duplicate.
Calibration curves were prepared by spiking working standards of each chemical in mobile
phase, as preliminary studies in pooled blank toad serum showed no matrix effects. Final con-
centration ranges for each chemical were as follows: benzoic acid: 0.25–62.4 μg/mL, ibuprofen:
0.3–6 μg/mL and caffeine: 0.195–200 μg/mL. All curves were linear with r2>0.999 for all runs.
Limit of quantification for each chemical was the lowest standard. The precision of the method
was assessed by injecting ten individual samples of a mid-range standard solution for each
chemical. Relative standard deviation of these injections was<1% for each chemical.
Data analysis and statistics
Developing a model of in vitro absorption for cane toads. Percutaneous absorption data
for the models were collected from a previous paper by the authors [13]. This data included
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flux of three model chemicals (caffeine, benzoic acid, and ibuprofen) across isolated cane toad
skin as tested using Franz diffusion cells. All data exploration and analyses were performed in
R [22]. Mean permeability coefficient (Kp) was calculated by dividing flux by the concentration
of chemical in the donor solution (Kp = Jss/Cv). Concentration of drug in the donor solution
(Cv) was the saturation solubility of each chemical in ARS, as reported in Llewelyn, Berger
[13]. Separate linear mixed-effects models with different combinations of predictor variables
and interactions between predictor variables were created to determine the relationship
between absorption (flux or Kp) and skin region of application, animal weight, and physico-
chemical properties of the applied chemical [logP or molecular weight (MW)]. As data
included three chemicals, MW and logP could not both be included as covariates in the same
model, and so their influence was investigated individually. Skin region was categorical and
included three factor levels: dorsal, ventral thoracic and ventral pelvic. Models using both stan-
dard and logarithm-transformed values of Kp and flux were developed and compared. Linear
mixed-effects models were fitted by maximum likelihood using the lme function in the nlme
package [23]. All models included the individual animal as a random effect, and models that
allowed and did not allow for heteroskedasticity in data were examined. Models were com-
pared using ANOVA, Akaike’s Information Criterion, and examination of residual plots to
determine best fit. The top models, defined as those with the largest statistical significance
from the null model while being not significantly different from each other (p>0.05), were
then examined for trends in independent variables. The best model, determined through a
combination goodness-of-fit analyses and parsimony, was then re-fitted using restricted maxi-
mum likelihood to obtain the coefficients used to predict chemical flux for each model chemi-
cal and skin region for comparison to in vivo values determined in this study.
Analysis of in vivo data. In order to allow direct comparison of predictions from in vitro
data and in vivo results, the average absorption per cm2 of skin surface area (SA) exposed to the
bathing solution was calculated. As the nominal amount of bathing solution used in the study
was chosen to provide drug exposure to the ventral pelvis only, skin SA for each individual was
estimated using the equation of Tracy [24], which states that the SA of a frog’s ventral pelvis in
contact with substrate when in a sitting position can be calculated from total body mass as:
SApelvic ventrum ¼ 1:15�½body massðgÞ�
0:559
Mean cumulative absorption versus time plots were produced for each chemical. Mean flux
(μg/cm2/h) was determined for each chemical from the steady-state slope of the cumulative
absorption versus time plot, and Kp was calculated as outlined above. Resultant in vivo flux
and Kp were compared to those predicted from the top in vitro flux models for cane toads.
Serum concentrations were compared to those predicted from the top in vitro models. Factor-
of-difference (FOD) was calculated as the ratio between the in vitro-based model predictions
and the observed in vivo values.
Results
Models for in vitro absorption in cane toads
Residual plots showed that models using logFlux were consistently better than those using
flux, regardless of whether MW or logP were used. The results will therefore focus on models
utilising logFlux. Conversely, using Kp produced better predictive models for both physico-
chemical parameters than log Kp, and so models presented use Kp not logKp.
When investigating the important predictors of logFlux, the effect of logP and MW were
investigated individually, and top models for each selected (Table 1). Five MW-containing
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models and six logP-containing models were identified as top models. For MW models, all the
top models allowed for heteroskedasticity of data by MW, whereas for logP models, allowing
for heteroskedasticity in both logP and skin region produced the top models.
Comparison of the logP- and MW-containing models showed that logP was consistently a
better predictor of logFlux than MW. Indeed, even the worst-performing model containing
logP as a predictor variable was significantly better than the best MW-containing model (L-
ratio6,8 = 37.07598, p<0.0001). For the logP models, logP and skin region of application were
found to be important predictors of logFlux, appearing in all of the top models. Animal weight
was also important, but not essential, for better model fit, appearing in 5/6 of the top models.
Molecular weight was not a good predictor of logFlux, as inclusion of MW in models
decreased the model fit, however if MW was included in a model, animal weight became an
important predictor variable for all models. Following comparison of goodness-of-fit and par-
simony, F.logP-4 was selected as the top model and was used to predict flux values for the in
vivo experiment. This model did not include weight as a predictive variable and allowed for
heteroskedasticity in both logP and skin region of application.
When investigating the important predictors of Kp, three top models for logP and four top
models for MW were identified (Table 2). Interestingly, whereas allowing for heteroskedasti-
city in logP and skin region improved model fits for all logFlux models, the best Kp models
including logP allowed for heteroskedasticity in logP only. Additionally, unlike the logFlux
models where all logP-containing models consistently outperformed even the top MW-con-
taining models, the top models were generally more similar, regardless of physicochemical
parameter used. The exceptions were K.logP-9, which was significantly better than 50% of the
MW models (models K.MW-17 and K.MW-25; L-ratio16,10 = 13.84304, p = 0.0314 and L-
ratio16,11 = 12.08116, p = 0.0337 respectively), and K.logP-25, which also outperformed MW-
17 (L-ratio11,10 = 5.986835, p = 0.0144).
For logP-containing models, both logP and skin region of application were important fac-
tors in predicting Kp, appearing in all top models. Animal weight was also important, but not
essential, for good model fit, appearing in 2/3 of the top logP models. Similar trends were seen
Table 1.
Models including logP
Model LogP Weight SubRegion
F.logP-1 + + +
F.logP-4� + +
F.logP-9 X X X
F.logP-17 X X +
F.logP-25 + X X
F.logP-28 X X
Models including MW
Model MW Weight SubRegion
F.MW-1 + + +
F.MW-6 + +
F.MW-9 X X X
F.MW-17 X X +
F.MW-25 X + X
Top models for predicting logFlux in cane toads. +: additive effect, X: interaction.
�best model—used to predict values for experiments
https://doi.org/10.1371/journal.pone.0235737.t001
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in the MW models, with all three factors contributing to the top models. Following compari-
son of goodness-of-fit and parsimony, K.logP-28 was selected as the model to be used to pre-
dict Kp values for the in vivo experiment. This model did not include weight as a predictive
variable and allowed for heteroskedasticity in logP only.
The final models of absorption, used for predictions of in vivo absorption parameters, are
presented in Tables 3 and 4.
In vivo absorption of benzoic acid, caffeine, and ibuprofen
Benzoic acid absorption was the most consistent and least variable between frogs (Fig 1), with
steady-state achieved at 90–120 minutes and maintained thereafter. In vivo ibuprofen levels
increased over the first 30 minutes to 0.5687 μg/mL, and remained relatively constant for the
remainder of the study (serum range over remaining sampling points: 0.415–0.852 μg/mL; Fig 2).
Variability between individuals and sampling times changed in the ibuprofen study, being quite
small at some sampling times, and large at others. No apparent trends in this variability were noted.
Caffeine absorption was rapid up until t = 15 minutes (Fig 3), with a reduction in serum levels
noted at the next sampling time (t = 20 minutes) indicative of elimination. Of note is that this reduc-
tion in serum levels at t = 20 minutes had the least inter-individual variability of all sampling times,
suggesting relatively consistent absorption and elimination kinetics of caffeine in these animals.
Predicted versus observed values of flux and Kp for benzoic acid, caffeine,
and ibuprofen
Values of flux and Kp, predicted using models F.logP-4 and K.logP-28, respectively, and as
measured in the in vivo studies, are presented in Table 5. While the predicted values of flux
Table 2.
Models including logP
Model LogP Weight SubRegion
K.logP-9 X X X
K.logP-25 X + X
K.logP-28� X X
Models including MW
Model MW Weight SubRegion
K.MW-6 + +
K.MW-9 X X X
K.MW-17 X X +
K.MW-25 X + X
Top models for predicting Kp in cane toads. +: additive effect, X: interaction.
�best model—used to predict values for experiments
https://doi.org/10.1371/journal.pone.0235737.t002
Table 3.
Skin Region Equation Standard deviations
Intercept Residual
Dorsal logFlux = 1.869444−0.438706LogP 0.089362 0.059183
Thoracic logFlux = 1.817442−0.438706LogP
Pelvic logFlux = 1.915197−0.438706LogP
Equations to predict flux through different skin regions in Rh. marina. Model F.logP-4 was used to produce these equations.
https://doi.org/10.1371/journal.pone.0235737.t003
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and Kp were consistently higher than observed, the FOD between the predicted and observed
values for Kp and flux, for each chemical, was very similar. The smallest FOD was seen for ben-
zoic acid (4.7 for flux and 4.9 for Kp), and the largest for ibuprofen (34.2 and 32.6 for flux and
Kp, respectively).
Predicted and measured serum concentrations at conclusion of exposure
time
Table 6 presents the predicted and observed serum concentrations for all three chemicals at
their final sampling time. Predictions from both models were similar, with serum levels differ-
ing by no more than 4 μg/mL/cm2. All in vivo serum concentrations were lower than pre-
dicted, with the FOD ranging from ~2.58 (caffeine) to ~10.25 (ibuprofen). Interestingly, F.
logP-4 more accurately predicted benzoic acid levels, whereas F.LogP-28 resulted in slightly
lower FOD for caffeine and ibuprofen.
Discussion
To determine the utility of extrapolating in vitro data to predict in vivo absorption following
topical chemical exposure in frogs, the current study created models of absorption in the cane
toad from in vitro absorption data, and then compared absorption kinetic values predicted by
the model to in vivo absorption parameters measured in the same species.
Table 4.
Skin Region Equation Standard deviations
Intercept Residual
Dorsal Kp = 0.00318−0.000125LogP 0.000679 0.000552
Thoracic Kp = 0.003641−0.000302LogP
Pelvic Kp = 0.004381−0.000373LogP
Equations to predict permeability coefficient (Kp) through different skin regions in Rh. marina. Model K.logP-28 was used to produce these equations.
https://doi.org/10.1371/journal.pone.0235737.t004
Fig 1. Mean cumulative absorption versus time curves for the in vivo absorption of benzoic acid in cane toads.
Each in vivo data point represents the mean of four animals (N = 4) and error bars are SEM.
https://doi.org/10.1371/journal.pone.0235737.g001
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In designing a model of percutaneous absorption in frogs, Kp and flux were both best-
described by logP, not MW. Indeed, in the case of flux predictions, the top MW models per-
formed worse than the poorest-fitting logP-based model. These results are perhaps unsurpris-
ing; the model drugs chosen in this study are recommended for use in percutaneous
absorption studies because they represent a limited range of MW (122.12–206.29 Da), while
providing a wide range in logP (–0.07 to 3.97). This is because in empirical models of percuta-
neous absorption in humans, logP has been found to be the primary determinant of absorption
rate [25], with MW having a smaller role in regulating the absorption process. As frog skin is
known to be permeable to large molecules including hormones [8], it is unsurprising that with
the limited range of MW represented in the current model, MW did not significantly influence
Fig 2. Mean cumulative absorption versus time curves for the in vivo absorption of ibuprofen in cane toads. Each
in vivo data point represents the mean of four animals (N = 4) and error bars are SEM.
https://doi.org/10.1371/journal.pone.0235737.g002
Fig 3. Mean cumulative absorption versus time curves for the in vivo absorption of caffeine in cane toads. Each in
vivo data point represents the mean of four animals (N = 4) and error bars are SEM.
https://doi.org/10.1371/journal.pone.0235737.g003
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absorption. The impact of increasing MW on absorption rate in frog skin is a logical extension
of the current study.
The models developed emphasise the importance of considering the site of chemical appli-
cation in frogs, as all top models included both logP and skin region of application. In particu-
lar, ventral pelvic application increased absorption, especially for hydrophilic chemicals. Skin
site is known to affect absorption in mammals, with regional variation in absorption being
attributed to differences in skin thickness and follicle density. While frogs are hairless, there
can be significant differences in skin thickness and vascularity between skin regions, in partic-
ular between the pelvic ventrum and other skin regions [26, 27]. The pelvic ventrum in terres-
trial and arboreal frog species is a thin, highly vascularised region, allowing rapid uptake of
water from underlying substrate. The ability of this region to permit rehydration differs
between frog species, both from the same primary habitat and between habitats. Studies in
cane toads have found heightened uptake of water through this region, particularly in dehy-
drated individuals [26, 28], despite reports of similar skin thickness between the dorsal and
ventral surfaces. While absorption studies in frogs have traditionally investigated ventral ver-
sus dorsal surfaces, rarely is the ventral surface considered as two distinct regions for absorp-
tion. Visual inspection of the inner skin surface in toads shows a marked difference in the
density and thickness of the capillaries on the ventral surface—being larger and more densely
arranged in the pelvic region, and similar vascularity on the thoracic and dorsal skin surfaces
(personal observation). Further, previous studies in cane toads by the authors [13] showed sig-
nificantly higher absorption of a hydrophilic chemical through ventral pelvic skin compared to
ventral thoracic (or dorsal) skin; it is therefore important to delineate between the ventral pel-
vic and ventral thoracic regions when applying chemicals to the skin of frogs, to minimise
inadvertent over- or under-dosing.
The current study showed consistently lower in vivo values than predicted from in vitro
observations. This is consistent with others studies using diffusion cells to predict in vivo
absorption in frogs [11, 17], and has also been reported in mammalian studies [5, 6, 29].
Table 5.
Chemical Predicted values Observed values Factor-of-difference
Fluxa (μg/cm2/h) Kpb (x10−3; cm/h) Flux (μg/cm2/h) Kp (x10−3; cm/h) Flux Kp
Caffeine 88.289 4.408 7.181 0.359 12.295 12.279
Benzoic acid 12.440 3.684 2.653 0.744 4.689 4.952
Ibuprofen 1.491 2.901 0.044 0.089 33.886 32.596
Predicted (in vitro) and observed (in vivo) values, and factor-of-difference between them, for the flux and Kp three chemicals in pelvic ventral cane toad skin.
a: predicted using model F.logP-4
b: predicted using model K.logP-28
https://doi.org/10.1371/journal.pone.0235737.t005
Table 6.
Chemical Serum concentration (μg/mL/cm2) Factor-of-difference
Predicted F.logP-4 Predicted K.logP-28 Measured F.logP-4 K.logP-28
Caffeine 44.14451 44.08441 17.106 2.580645 2.577131
Benzoic acid 74.6396 78.77866 14.724 5.069248 5.350357
Ibuprofen 8.947212 8.529969 0.852 10.50142 10.0117
Predicted serum concentrations from each of the top models, measured serum concentrations at the final sampling time, and factor-of-difference between predicted and
measured values chemical
https://doi.org/10.1371/journal.pone.0235737.t006
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Additionally, despite this finding of lower overall absorption in vivo, all chemicals demon-
strated similar or more rapid initial in vivo absorption. The most extreme was benzoic acid,
which exhibited a 50% higher concentration in vivo at the initial sampling time compared to
previously-reported in vitro levels [13], whereas in vivo ibuprofen levels were marginally lower
at t = 30 minutes than the reported in vitro levels. Such a reduction in the overall in vivo levels
compared to predicted or observed in vitro values is not unexpected, as in vitro experiments
represent an isolated process (absorption), whereas in vivo there are competing processes of
elimination and distribution occurring concurrently with absorption. This was obviously a
contributing factor in the current study, as all three chemical absorption profiles appear to
have reached steady-state (Figs 1–3), and most animals urinated during the study. In order to
deconvolute the in vivo data, IV elimination pharmacokinetic data would be required. How-
ever, such data are rare in frogs, and does not exist for the chemicals studied. There have been
attempts to convert pharmacokinetic elimination data from other species (via allometric and/
or relative metabolic capacity) to apply to frogs [30], however results were variable between
chemicals studied, and for different frog species. Additionally, elimination pathways are likely
to be different between mammals and frogs, owing to known differences in microsomal
enzyme activities and renal function [31, 32]. Thus, it is inappropriate to use data from mam-
malian species in the current study to estimate elimination kinetics.
Despite the lower in vivo absorption values reported in the current study, reasonable corre-
lation was found between predicted absorption rates and observed in vivo absorption parame-
ters for benzoic acid and caffeine. Indeed, the FOD reported for benzoic acid and caffeine in
the current study are lower and similar to (respectively) those reported by Riviere, Shapiro
[11], who suggested that these levels provided a reasonable correlation, given the inherent dif-
ficulties with accurately extrapolating in vitro data to the in vivo situation. In addition to the
masking effects of concurrent elimination processes occurring in vivo, the assumption that
flux is constant from the start of dosing when predicting serum concentrations is another
potential source of error. A lag-phase has only been reported in frog skin in vitro when the
donor solution contains penetration enhancers [33]; as the first sample in the current study
was taken at 30 minutes, it is possible that the lag phase occurred prior to this sample being
taken. Disregarding even a short lag-time when predicting serum concentration would con-
tribute to the disparity between in vitro predictions and in vivo concentrations. Finally, while
an attempt has been made to estimate the surface area of skin exposed to the bathing solution,
extrapolation of dosing area from each animal’s weight is likely to have contributed to the dif-
ferences between in vitro predictions and in vivo observations in the current study.
Studies examining in vitro and in vivo absorption in mammals commonly report poorer
agreement between in vitro and in vivo values for hydrophilic chemical absorption [5, 29],
whereas the current study found the worst predictive power for ibuprofen, the most lipophilic
chemical. Despite these seemingly contradictory results, this difference can be explained by the
differences in skin composition and physiology between these animals. The stratum corneum
in mammals is a thick, largely lipophilic structure, and as such, retards absorption of hydro-
philic substances. However, the reverse is true in frogs when applying substances to the ventral
pelvic skin—an area honed for uptake of water—and so lipophilic substances have reduced
absorption. Additionally, substances absorbed to a lesser degree will result in an amplification
in any interindividual variability in pharmacokinetic processes [34], and so it is unsurprising
that lipophilic ibuprofen exhibited the poorest agreement between in vitro and in vivo absorp-
tion. Although within dermal absorption testing guidelines for sample sizes [20], the use of
only four animals per sampling time may have also contributed to these findings–as the inter-
individual variability would be more pronounced with fewer individuals contributing to the
data point.
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Finally, it should also be noted that any urine excreted would have been added to the bath-
ing solution, which would make the chemical available for reabsorption, while also slightly
diluting the bathing solution. This dilution of (and the addition of excreted chemical into) the
bathing solution is unlikely to impact absorption rate significantly as the bathing solution was
saturated with chemical, and so thermodynamics of the solution are unlikely to be significantly
affected by these small changes in chemical and bathing fluid levels. However, accumulation of
drug in the urine would reduce serum concentrations. Studies to ascertain baseline pharmaco-
kinetic elimination parameters for each model chemical will permit more detailed analysis of
the data presented herein.
Conclusions
Both models presented provide reasonable predictions of serum concentrations in vivo, partic-
ularly for moderately lipophilic and hydrophilic chemicals, and emphasise the importance of
considering both application site and physicochemical properties when considering percuta-
neous absorption in frogs. However, similar to the seminal work off Franz [6] on the relevance
of in vitro studies to in vivo human percutaneous absorption, although the findings of the cur-
rent study suggest a moderate agreement between in vitro and in vivo absorption in frogs, fur-
ther work is needed to produce more harmonious absorption data to refine the model.
In particular, investigations into the in vivo pharmacokinetics, including IV administration,
of these model chemicals will permit deconvolution of the data and offer the ability to separate
the absorption phase from elimination. Another logical step would be to further investigate
the utility of this model by using it to predict the serum concentration following topical
administration of a chemical for use in the treatment of disease in frogs, and to then investigate
and compare the in vivo absorption of this chemical with the predictions. It is likely that the
findings herein will provide a useful method to estimate the in vivo absorption of hydrophilic
and moderately-lipophilic chemicals through frog skin, and could therefore be used in predict-
ing absorption when formulating chemicals for treatment of disease in frogs.
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